← Back to Search

Dietary Supplement

AC-11 for Aging

Phase 2
Waitlist Available
Led By Phillip Gallegos
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in epigenetic age from baseline to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a dietary supplement called AC-11® on 24 patients over several months. The goal is to see if the supplement can reverse genetic signs of aging. Changes in DNA that affect gene function will be measured to determine effectiveness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in epigenetic age from baseline to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in epigenetic age from baseline to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Methylation age clock testing
Telomere Test

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AC-11Experimental Treatment1 Intervention
6 months of treatment with AC-11

Find a Location

Who is running the clinical trial?

TruDiagnosticLead Sponsor
11 Previous Clinical Trials
454 Total Patients Enrolled
8 Trials studying Aging
344 Patients Enrolled for Aging
Optigenex, IncUNKNOWN
Phillip GallegosPrincipal InvestigatorThrive Medicine Clinic
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top